Frontier Medicines Corporation

Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, pain, peripheral neuropathy, inflammatory disease, autoimmune disease, ulcerative colitis, atopic dermatitis, plaque psoriasis, chronic obstructive pulmonary disease, Crohn’s disease, eosinophilic esophagitis, systemic lupus erythematosus, multiple sclerosis, age-related diseases, rare diseases, and pediatric diseases in humans

Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, pain, peripheral neuropathy, inflammatory disease, autoimmune disease, ulcerative colitis, atopic dermatitis, plaque psoriasis, chronic obstructive pulmonary disease, Crohn’s disease, eosinophilic esophagitis, systemic lupus erythematosus, multiple sclerosis, age-related diseases, rare diseases, and pediatric diseases in humans; No claim is made to the exclusive right to use MEDICINES, apart from the mark as shown.

Pharmaceutical research and development; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical drug development services

Small molecule pharmaceuticals for the treatment of cancer; Pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer

Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans

Class 005: Small molecule pharmaceuticals for the treatment of cancer; Class 042: pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer

"MEDICINES"

Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans; "MEDICINES"

Class 005: Pharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, Amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans

Pharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, neurodegenerative disease, neuropsychiatric disorders, cardiometabolic disease, diseases of the eye, dermatological diseases, pain, monogenic disorders, and hereditary diseases

Pharmaceutical research and development; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical drug development services